| abstract |
(57) [Summary]nThe invention features formulations, including liquid, semi-solid, or solid pharmaceutical formulations, that improve the oral bioavailability of hydrophobic drugs such as quinazoline-based compounds, nitrothiazole-based compounds, and indolinone-based compounds. . The invention also features formulations for parenteral delivery of such hydrophobic drugs, as well as methods of making and using both types of formulations. |